Big bid for green stocks as EU vaccine woes continue
Teeranon - stock.adobe.com
Europe’s slow rollout of Covid-19 vaccines is beginning to damage confidence in a quick economic rebound this year, leading some investors to step back from value trades in pandemic-exposed cyclical stocks and enter new positions in high-growth momentum trades, particularly renewable energy stocks.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts